ADC Therapeutics to Present at Upcoming Investor Conferences
Provided By PR Newswire
Last update: May 15, 2025
LAUSANNE, Switzerland, May 15, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in two upcoming investor conferences:
Read more at prnewswire.com
